# COMPARISON OF WARFARIN AND RIVAROXABAN IN THE TREATMENT OF LOWER LIMB DEEP VENOUS THROMBOSIS

> **NCT07077954** · PHASE1 · COMPLETED · sponsor: **Children Hospital and Institute of Child Health, Lahore** · enrollment: 74 (actual)

## Conditions studied

- Deep Vein Thrombosis (DVT)

## Interventions

- **DRUG:** Rivaroxaban
- **DRUG:** Warfarin

## Key facts

- **NCT ID:** NCT07077954
- **Lead sponsor:** Children Hospital and Institute of Child Health, Lahore
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-20
- **Primary completion:** 2023-06-19
- **Final completion:** 2023-06-20
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2025-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07077954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07077954, "COMPARISON OF WARFARIN AND RIVAROXABAN IN THE TREATMENT OF LOWER LIMB DEEP VENOUS THROMBOSIS". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07077954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
